Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Finlayson

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1979
Immune globulinsJ S Finlayson
Annals of the New York Academy of Sciences|December 8, 1972
Human fibrinogen free of factor XIII: the pursuit of biological zeroJ S Finlayson
Annals of the New York Academy of Sciences|June 27, 1983
"Fibrinogen Oklahoma": a study of interactionsJ S Finlayson
American Journal of Hospital Pharmacy|August 1, 1978
The birth and demise of "salt-poor" albuminJ S Finlayson
Seminars in Thrombosis and Hemostasis|January 1, 1979
Therapeutic plasma fractions and plasma fractionation (prologue)J S Finlayson
Biophysical Chemistry|February 4, 2005
John Ferry--the most important man I never knewJ S Finlayson
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Approaches to the structure of fibrinogenJ S Finlayson
Developments in Biological Standardization|January 1, 1993
Regulation of plasma derivatives in the U.S.AJ S Finlayson
Lancet (London, England)|October 5, 1991
Immunoglobulin therapyJ S Finlayson, D L Tankersley
Lancet (London, England)|May 26, 1990
Anti-HCV screening and plasma fractionation: the case againstJ S Finlayson, D L Tankersley
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Seminars in Thrombosis and Hemostasis|January 1, 1979
Immune globulinsJ S Finlayson
Annals of the New York Academy of Sciences|December 8, 1972
Human fibrinogen free of factor XIII: the pursuit of biological zeroJ S Finlayson
Annals of the New York Academy of Sciences|June 27, 1983
"Fibrinogen Oklahoma": a study of interactionsJ S Finlayson
American Journal of Hospital Pharmacy|August 1, 1978
The birth and demise of "salt-poor" albuminJ S Finlayson
Seminars in Thrombosis and Hemostasis|January 1, 1979
Therapeutic plasma fractions and plasma fractionation (prologue)J S Finlayson
Biophysical Chemistry|February 4, 2005
John Ferry--the most important man I never knewJ S Finlayson
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Approaches to the structure of fibrinogenJ S Finlayson
Developments in Biological Standardization|January 1, 1993
Regulation of plasma derivatives in the U.S.AJ S Finlayson
Lancet (London, England)|October 5, 1991
Immunoglobulin therapyJ S Finlayson, D L Tankersley
Lancet (London, England)|May 26, 1990
Anti-HCV screening and plasma fractionation: the case againstJ S Finlayson, D L Tankersley
Pageof 7